The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Spatially resolved multi-region transcriptomic subtyping and assessment of gene expression profiles associated with long-term benefit from chemo-immunotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC).
 
Melina Peressini
No Relationships to Disclose
 
Rosario Garcia Campelo
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Roche; Sanofi/Aventis; Takeda
Travel, Accommodations, Expenses - MSD Oncology; Pfizer; Roche/Genentech
 
Manuel Cobo-Dols
No Relationships to Disclose
 
Manuel Domine
Consulting or Advisory Role - AstraZeneca; MSD Oncology; Pfizer; Roche; Takeda
 
Javier de Castro Carpeño
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Lilly O.; Merck Sharp & Dohme; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Merck Sharp & Dohme; Roche
 
Jose Fuentes Pradera
Consulting or Advisory Role - MSD Oncology; Roche/Genentech
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Medarex; Pfizer; Sanofi; Takeda
Research Funding - BeiGene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Roche/Genentech (Inst)
Other Relationship - Pfizer
 
Juan Felipe Cordoba
No Relationships to Disclose
 
Emilio Esteban
Travel, Accommodations, Expenses - Pfizer/EMD Serono; Pfizer/EMD Serono
 
Enric Carcereny
Consulting or Advisory Role - AstraZeneca Spain; Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche/Genentech; Takeda
Speakers' Bureau - AstraZeneca Spain; BMSi; MSD Oncology; Roche; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche; Takeda
 
Laia Vilà
Honoraria - AstraZeneca Spain; Pfizer; Roche; Sanofi/Regeneron
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Takeda
 
Alberto Moreno
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Silverio Ros Martinez
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Sanofi
Travel, Accommodations, Expenses - Ipsen
 
Gerardo Huidobro Vence
No Relationships to Disclose
 
Bartomeu Massuti
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Janssen; Merck Serono; Roche
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche; Sanofi/Regeneron
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; MSD Oncology; Roche
 
Magdalena Molero
No Relationships to Disclose
 
Vera Adradas
No Relationships to Disclose
 
Esther Conde
Honoraria - AstraZeneca; Lilly O.; Pfizer; Roche
Research Funding - Roche (Inst); Thermo Fisher Scientific (Inst)
 
Santiago Ponce Aix
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo; GlaxoSmithKline; Janssen; Lilly; Medscape; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Regeneron; Roche/Genentech; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Jon Zugazagoitia
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Guardant Health; NanoString Technologies; Pfizer; Roche/Genentech; Sanofi/Regeneron
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; Novartis; Novartis; Pfizer; Sanofi/Regeneron
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; MSD Oncology; NanoString Technologies; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Roche/Genentech